J Liao, J Lin, D Lin, C Zou,
J Kurata,
R Lin, Z He… - Scientific Reports, 2017 - nature.com
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are standard
treatments for advanced non-small-cell lung cancer (NSCLC) patients. However, acquired …